Congenital malformation of circulatory system, unspecified
Conditions
Interventions
This is a double-blind, randomized, placebo-controlled trial at a pediatric intensive care unit in a Brazilian tertiary-care university hospital. The randomization will be in blocks of random size (4
Sponsors
Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo
Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo
Eligibility
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: Children with congenital heart disease; both genders; age between 0 and 18 years; undergoing heart surgery
Exclusion criteria
Exclusion criteria: Parental request; intraoperative death; hemodynamic instability
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 2: We expect to find a decrease in pain caused by lidocaine, assessed by the face, legs, activity, cry, consolability pain scale – revised (FLACC-R);Observed outcome 2: We did not find a decrease in pain caused by lidocaine, assessed by the face, legs, activity, cry, consolability pain scale – revised (FLACC-R) | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 1: We expect to find an increase in pain caused by respiratory therapy, assessed by the face, legs, activity, cry, consolability pain scale – revised (FLACC-R);Observed outcome 1: We did not find an increase in pain caused by respiratory therapy, assessed by the face, legs, activity, cry, consolability pain scale – revised (FLACC-R) | — |
Countries
Brazil
Contacts
Public ContactFabio Carmona
Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo
Outcome results
None listed